1. Home
  2. ITRI vs CYTK Comparison

ITRI vs CYTK Comparison

Compare ITRI & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRI
  • CYTK
  • Stock Information
  • Founded
  • ITRI 1977
  • CYTK 1997
  • Country
  • ITRI United States
  • CYTK United States
  • Employees
  • ITRI N/A
  • CYTK N/A
  • Industry
  • ITRI Electrical Products
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • ITRI Industrials
  • CYTK Health Care
  • Exchange
  • ITRI Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • ITRI 5.0B
  • CYTK 5.6B
  • IPO Year
  • ITRI 1993
  • CYTK 2004
  • Fundamental
  • Price
  • ITRI $115.60
  • CYTK $31.02
  • Analyst Decision
  • ITRI Strong Buy
  • CYTK Buy
  • Analyst Count
  • ITRI 10
  • CYTK 15
  • Target Price
  • ITRI $126.80
  • CYTK $73.71
  • AVG Volume (30 Days)
  • ITRI 505.3K
  • CYTK 2.4M
  • Earning Date
  • ITRI 05-01-2025
  • CYTK 05-06-2025
  • Dividend Yield
  • ITRI N/A
  • CYTK N/A
  • EPS Growth
  • ITRI 57.53
  • CYTK N/A
  • EPS
  • ITRI 5.48
  • CYTK N/A
  • Revenue
  • ITRI $2,444,546,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • ITRI $3.00
  • CYTK $24.01
  • Revenue Next Year
  • ITRI $5.85
  • CYTK $698.33
  • P/E Ratio
  • ITRI $21.09
  • CYTK N/A
  • Revenue Growth
  • ITRI 7.10
  • CYTK 412.21
  • 52 Week Low
  • ITRI $90.11
  • CYTK $29.31
  • 52 Week High
  • ITRI $124.90
  • CYTK $61.38
  • Technical
  • Relative Strength Index (RSI)
  • ITRI 61.20
  • CYTK 39.05
  • Support Level
  • ITRI $110.54
  • CYTK $30.02
  • Resistance Level
  • ITRI $116.03
  • CYTK $31.27
  • Average True Range (ATR)
  • ITRI 2.27
  • CYTK 1.40
  • MACD
  • ITRI -0.11
  • CYTK 0.24
  • Stochastic Oscillator
  • ITRI 86.05
  • CYTK 42.12

About ITRI Itron Inc.

Itron Inc provides solutions that measure, manage, and analyze energy and water use. It operates under the Itron brand and manages and reports under three operating segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment includes hardware products used for measurement, control, or sense that do not have communications capability embedded for use with broader Itron systems. The Networked Solutions segment includes a combination of communicating devices, network infrastructure, and associated application software designed and sold as a complete solution. The Outcome segment includes their value-added, enhanced software and services which manage, organize, analyze, and interpret data to improve decision-making and maximize operational profitability.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: